Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-nave patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
Vision Loss from Ozempic, Wegovy, or Mounjaro
Gandhi VV, Gandhi KA, Goda JS et al (2023) Post-radiation treatment of 3,3-diselenodipropionic acid augments cell kill by modulating DNA repair and cell migration pathways in A549 cells
Its either we stay up late at night trying to finish whatever things we need for the next day
2 Emerging research in healthspan and longevity: In studies, Tirzepatide supported a favorable shift in body composition, more fat loss with preserved lean mass, while modulating inflammatory pathways and supporting cardiovascular health
The Role of Personalized Treatment Every body reacts differently to GLP-1 medications